U.S. RESEARCH ROUNDUP- BorgWarner, Doma Holdings, Visteon

Innate Pharma SA

20/09/2021 08:05

Sept 20 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including BorgWarner, Doma Holdings and Visteon on Monday. 
    
    HIGHLIGHTS
     * BorgWarner Inc  BWA.N : Jefferies cuts to hold from buy; cuts PT to $47 from $55
     * Doma Holdings Inc  DOMA.N : Oppenheimer starts with outperform rating; price target $11
     * Visteon Corp  VC.O : Jefferies raises to buy from hold; cuts PT to $116 from $122
        
Following is a summary of research actions on U.S. companies reported by Reuters on Monday.
Stock entries are in alphabetical order. 
    
     * Aptiv Plc  APTV.N : Jefferies cuts target price to $184 from $190
     * BorgWarner Inc  BWA.N : Jefferies cuts to hold from buy; cuts PT to $47 from $55
     * Brp Group Inc  BRP.O : JP Morgan raises price target to $36 from $33
     * Doma Holdings Inc  DOMA.N : Oppenheimer starts with outperform rating; price target $11
     * Evoqua Water Technologies Corp  AQUA.N : Stifel raises price target to $45 from $41
     * Forum Energy Technologies Inc  FET.N : Piper Sandler raises target price to $30 from $28
     * Gentex Corp  GNTX.O : Jefferies cuts target price to $38 from $39
     * Innate pharma SA  IPHA.O : Evercore ISI raises target price to $10 from $6
     * Leap Therapeutics Inc  LPTX.O : Piper Sandler raises target price to $5 from $4
     * Lear Corp  LEA.N : Jefferies cuts to hold from buy; cuts target price to $171 from $200
     * Lincoln National Corp  LNC.N : Evercore ISI raises target price to $90 from $86
     * Lincoln National Corp  LNC.N : Piper Sandler raises price target to $73 from $70
     * Mirum Pharmaceuticals Inc  MIRM.O : JP Morgan starts with overweight rating; PT $30
     * Molina Healthcare Inc  MOH.N : Credit Suisse raises price target to $318 from $280
     * One Group Hospitality Inc  STKS.O : Piper Sandler raises to overweight from neutral
     * One Group Hospitality Inc  STKS.O : Piper Sandler raises target price to $17 from $12
     * Oscar Health Inc  OSCR.N : Credit Suisse cuts price target to $26 from $34
     * Protagonist Therapeutics Inc  PTGX.O : Jefferies cuts target price to $29 from $60
     * Protagonist Therapeutics Inc  PTGX.O : JP Morgan cuts price target to $49 from $60
     * Protagonist Therapeutics Inc  PTGX.O : JP Morgan cuts to neutral from overweight
     * Ruth's Hospitality Group Inc  RUTH.O : Piper Sandler raises to overweight from neutral
     * Ruth's Hospitality Group Inc  RUTH.O : Piper Sandler raises target price to $28 from $25
     * Sprout Social Inc  SPT.O : BTIG raises price target to $150 from $110
     * TCR2 Therapeutics Inc  TCRR.O : SVB Leerink cuts price target to $18 from $31
     * TCR2 Therapeutics Inc  TCRR.O : Wedbush cuts price target to $11 from $45
     * TCR2 Therapeutics Inc  TCRR.O : Wedbush cuts to neutral from outperform
     * Thermo Fisher Scientific Inc  TMO.N : JP Morgan raises price target to $700 from $600
     * Visteon Corp  VC.O : Jefferies raises to buy from hold; cuts PT to $116 from $122
 

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))